The U.S. Food and Drug Administration (FDA) issued a Letter to Health Care Providers recommending that health care providers, laboratory personnel, and facilities stop using the Quidel Triage Cardiac Panel, manufactured by Quidel Cardiovascular Inc. (QuidelOrtho), and use an alternative method, or an alternate local testing site if available.